Announced details
Regenerative medicine products and CAR-T cell therapy
Not disclosed (cytotoxic activity and persistence of activity in some HLH-CAR-αβT cells were confirmed)
The company is conducting joint research with Osaka Metropolitan University.
A university to which the group of Specially Appointed Professor Ikuo Fujii, who is advancing the development of HLH peptides, belongs. Other information, including its location, representative, capital and year of establishment, is not disclosed.
Kyoto University Shiran Kaikan (venue for the academic meeting)
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
23rd Annual Meeting of the Japanese Society for Immunotherapy
| Item | Details |
|---|---|
| Names of Products / Services Covered | Novel CAR-T cells using an HLH peptide in the antigen-recognition domain |
| Counterparty | Osaka Metropolitan University |
| Counterparty overview | A university to which the group of Specially Appointed Professor Ikuo Fujii, who is advancing the development of HLH peptides, belongs. Other information, including its location, representative, capital and year of establishment, is not disclosed. |
| Relationship with the Company | The company is conducting joint research with Osaka Metropolitan University. |
| Applicable area | Regenerative medicine products and CAR-T cell therapy |
| Location | Kyoto University Shiran Kaikan (venue for the academic meeting) |
| Quantitative Effects | Not disclosed (cytotoxic activity and persistence of activity in some HLH-CAR-αβT cells were confirmed) |
| Source | 23rd Annual Meeting of the Japanese Society for Immunotherapy |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Antigen-specific cytotoxic activity was confirmed in both αβ T cells and γδ T cells using CAR-T cells incorporating an HLH peptide, and persistence of activity was also demonstrated in some cases.